Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Quote. Real-time Euronext Paris - 01/27 06:41:20 am
92.52 EUR   +0.63%
05:40aSANOFI : Goldman Sachs remains its Buy rating
MD
01/26SANOFI : JP Morgan reiterates its Buy rating
MD
01/26Business investment into Singapore dropped 31% in 2021
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : UBS gives a Buy rating

11/29/2021 | 07:10am EST

In his latest research note, analyst Laura Sutcliffe confirms his positive recommendation. The broker UBS is keeping its Buy rating. The target price is being increased from EUR 100 to EUR 116.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
05:40aSANOFI : Goldman Sachs remains its Buy rating
MD
01/26SANOFI : JP Morgan reiterates its Buy rating
MD
01/26Business investment into Singapore dropped 31% in 2021
RE
01/26Business investment into Singapore dropped 31% in 2021
RE
01/25SANOFI : Disclosure of trading in own shares
PU
01/25Liberum Reinstates Sanofi With Buy Rating
MT
01/24SANOFI : Second positive Phase 3 Dupixent« (dupilumab) trial confirms significant improvem..
PU
01/21SANOFI : Early redemption / Cancellation / Delisting
PU
01/20Exclusive-Polish drug maker Polpharma working on bid for Advent's Zentiva - sources
RE
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 790 M 42 321 M 42 321 M
Net income 2021 6 141 M 6 877 M 6 877 M
Net Debt 2021 9 936 M 11 127 M 11 127 M
P/E ratio 2021 18,9x
Yield 2021 3,59%
Capitalization 115 B 130 B 129 B
EV / Sales 2021 3,32x
EV / Sales 2022 3,04x
Nbr of Employees 99 412
Free-Float -
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 91,94 €
Average target price 107,27 €
Spread / Average Target 16,7%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Director
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI3.79%130 219
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642